Phase II trial of arsenic trioxide in relapsed and refractory acute myeloid leukemia, secondary leukemia and/or newly diagnosed patients at least 65 years old

Simrit Parmar, Lynn M. Rundhaugen, Larry Boehlke, Mary Beth Riley, Chadi Nabhan, Adekunle Raji, John L. Frater, Martin S. Tallman

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of arsenic trioxide in relapsed and refractory acute myeloid leukemia, secondary leukemia and/or newly diagnosed patients at least 65 years old'. Together they form a unique fingerprint.

Medicine & Life Sciences